Controversies in the management of Graves' disease

Clinical Endocrinology

Volumn 49, Issue 3, 1998, Pages 273-280

  Leech, Nicky J ^a   Dayan, Colin M ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; LIOTHYRONINE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE; THYROXINE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTHRALGIA; CLINICAL TRIAL; DOSE RESPONSE; ENDOCRINE OPHTHALMOPATHY; EUROPE; GASTRITIS; GRAVES DISEASE; HUMAN; LIVER TOXICITY; MAINTENANCE THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SKIN MANIFESTATION; THYROIDECTOMY; UNITED STATES;

ANTITHYROID AGENTS; DRUG ADMINISTRATION SCHEDULE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS; RECURRENCE; THYROIDECTOMY;

EID: 0031781156     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00558.x     Document Type: Review

References (53)

1. Allanic, R., Faucet, R., Orgiazzi, J., Madec, A.M., Genetet, B., Lorcy, A., Le Guerrier, A.M., Delambre, C. & Derennes, V. (1990) Antithyroid Drugs and Graves' Disease: A prospective randomized evaluation of the efficacy of treatment duration. Journal of Clinical Endocrinology and Metabolism, 70, 675-679.
2. Arab, D.M., Malatjalian, D.A. & Rittmaster, R.S. (1995) Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. Journal of Clinical Endocrinology and Metabolism, 80, 1083-1085.
3. Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M.L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M.P., Lepri, A., Rossi, G., Martino, E. & Pinchera, A. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine, 338, 73-78.
4. Benker, G., Vitti, P., Kahaly, G., Raue, F., Tegler, L., Hirche, H., Reinwein, D. & The European Multicentre Study Group (1995) Response to methimazole in Graves' disease. Clinical Endocrinology, 43, 257-263.
5. Bing, R.F. & Rosenthal, F.D. (1982) Early remission in thyrotoxicosis produced by short courses of treatment. Acta Endocrinolgica, 100, 221-223.
6. Burch, H.B., Solomon, B.L., Wartofsky, L. & Burman, K. (1994) Discontinuing antithyroid drug treatment before ablation with radioiodine in Graves' disease. Annals of Internal Medicine, 121, 553-559.
7. Cusick, E.L., Krukowski, Z. H. & Matheson, N.A. (1987) Outcome of surgery for Graves' disease re-examined. British Journal of Surgery, 74, 780-783.
8. De Groot, L.J., Gorman, C.A., Pinchera, A., Bartelena, L., Marocci, C., Wiersinga, W.M., Prummel, M.F. & Wartofsky, L. (1995) Therapeutic Controversies. Radiation and Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 80, 339-349.
9. Edwards, C.J. & Tellez, M. (1994) Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose. European Journal of Endocrinology, 131, 120-124.
10. Feldt-Rasmussen, U., Schleusener, H. & Carayon, P. (1994) Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 78, 98-102.
11. Feliciano, D.V. (1992) Everything you wanted to know about Graves' disease. American Journal of Surgery, 164, 404-411.
12. Franklyn, J.A., Daykin, J., Droic, Z., Farmer, M. & Sheppard, M.C. (1991) Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology, 34, 71-76.
13. Glinoer, D., Hesch, D., Lagasse, R. & Laurberg, P. (1987) The Management of hyperthyroidism due to Graves' Disease in Europe in 1986. Results of an international survey. Acta Endocrinolgica, 185, 9-37.
14. Gomez, N., Gomez, J.M., Orti, A., Gavaldà, L., Villabona, C., Leyes, P. & Soler, J. (1995) Transient hypothyroidism after iodine-131 therapy for Graves' disease. Journal of Nuclear Medicine, 36, 1539-1542.
15. Gorton, C., Abdollah, S.N. & Boris, S. (1987) Remission in children with hyperthyroidism treated with propylthiouracil. American Journal of Diseases in Childhood, 141, 1084-1086.
16. Greer, M.A., Kammer, H. & Bouma, D.J. (1977) Short-term antithyroid drug treatment for the thyrotoxicosis of Graves' disease. New England Journal of Medicine, 297, 173-176.
17. Hashizume, K., Ichiikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kohayashi, M., Miyamoto, T., Arai, M. & Nagasawa, T. (1991) Administration of thyroxine in treated Graves' disease. New England Journal of Medicine, 324, 947-953.
18. Hedley, A.J., Young, R.E., Jones, S.J., Alexander, W.D., Bewsher, P.D. & Scottish Automated Follow-up Register Group (1989) Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 Patients. Clinical Endocrinology, 31, 209-218.
19. Jorde, R., Ytre-Arne, K., Stormer, J. & Sundsfjord, J. (1995) Short-term treatment of Graves' disease with methimazole in high versus low doses. Journal of Internal Medicine, 238, 161-165.
20. Kallner, G., Vitols, S. & Ljunggren, J.G. (1996) Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. Journal of Internal Medicine, 239, 525-529.
21. Koroscil, T.M. (1995) Thioamides alter the efficacy of radioiodine treatment in patients with Graves' disease. Southern Medical Journal., 88, 831-835.
22. Kuma, K., Matsuzuka, F., Kobayashi, M., Hirai, K., Fukata, S., Tamai, H., Miyauci, A. & Sugawara, M. (1991) Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction. American Journal of Medical Sciences, 302, 8-12.
23. Kung, A.W.C., Yau, C.C. & Cheng, A.C.K. (1995) The action of methimazole and L-thyroxine in radioiodine therapy - a prospective study of the incidence of hypothyroidism. Thyroid, 5, 7-13.
24. Laurberg, P., Bucholtz, P.E., Hansen, P.E., Iverson, E., Eskjaer, S. & Weeke, J. (1986) Goitre size and outcome of medical treatment of Graves' disease. Acta Endocrinolgica, 111, 39-43.
25. Lloyd, D., Hancock, R., Tuttle, M., LeMar, H., Bauman, J. & Patience, T. (1997) The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology, 47, 425-430.
26. Lucas, A., Salinas, I., Rius, F., Pizarro, E., Granada, M.L., Foz, M. & Sanmartí, A. (1997) Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? Journal of Clinical Endocrinology and Metabolism, 82, 2410-2413.
27. Marchant, B., Brownlie, B.E.W., McKay Hart, D., Horton, P.W. & Alexander, W.D. (1977) The placental transfer of propylthiouracil, methimazole and carbimazole. Journal of Clinical Endocrinology and Metabolism, 45, 1187-1193.
28. Marocci, C., Gianchecchi, D., Masini, L., Golia, F., Ceccarelli, C., Bracci, E. & Pinchera, G.F.A. (1990) A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. Journal of Endocrinological Investigation, 13, 513-520.
29. McIver, B., Rae, P., Beckett, G., Wilkinson, E., Gold, A. & Toft, A. (1996) Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. New England Journal of Medicine, 334, 220-224.
30. Meng, W., Meng, S., Mannchen, E., Hampel, R., Kirsch, G., Dannenberg, J. & Krabbe, S. (1991) Effect of duration of therapy and low and highly dosed thiamazole treatment on Basedow's-Graves' disease. Experimental and Clinical Endocrinology, 97, 257-260.
31. Meyergessner, M., Benker, G., Lederbogen, S., Olbricht, T. & Reinwein, D. (1994) Antithyroid drug-induced agranulocytosis - clinical experience with 10 patients treated at one institution and review of the literature. Journal of Clinical Investigations, 17, 29-36.
32. Miccoli, P., Vitti, P., Rago, T., Iacconi, P., Bartalena, L., Bogazzi, F., Fiore, E., Valeriano, R., Chiovato, L., Rocchi, R. & Pinchera, A. (1996) Surgical treatment of Graves' disease: subtotal or total thyroidectomy. Surgery, 120, 1020-1025.
33. Page, S.R., Sheard, C.E., Herbert, M., Hopton, M. & Jeffcoate, W.J. (1996) A comparison of 20 or 40mg per day of carbimazole in the treatment of hyperthyroidism. Clinical Endocrinology, 45, 511-515.
34. Pfeilschifter, J. & Zeigler, R. (1997) Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence hyperthyroidism and thyroid volume. European Journal of Endocrinology, 136, 81-86.
35. Reinwein, D., Benker, G., Lazarus, J.H., Alexander, W.D. & The European Multicenter Study Group on Antityroid Drug Treatment (1993) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. Journal of Clinical Endocrinology and Metabolism, 76, 1516-1521.
36. Rittmaster, R.S., Zwicker, H., Abbott, E.C., Douglas, R., Givner, M.L., Gupta, M.K., Lehmann, L., Reddy, S., Salisbury, S.R., Schlossberg, A.H., Tan, M.H. & York, S.E. (1996) Effect of methimazole with or without exogenous 1-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism, 81, 3283-3288.
37. Romaldini, J.H., Bromberg, N., Werner, R.S., Tanaka, L.M., Rodrigues, H.F., Werner, M.C., Farah, C.S. & Reis, L.C.F. (1983) Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 57, 563-570.
38. Solomon, B., Glinoer, D., Lagasse, R. & Wartofsky, L. (1990) Current trends in the management of Graves' disease. Journal of Clinical Endocrinologv and Metabolism, 70, 1518-1524.
39. Sridama, V., McCormick, M., Kaplan, E.L., Fauchet, R. & De Groot, L.J. (1984) Long-term follow-up study of compensated low-dose I-131 therapy for Graves' disease. New England Journal of Medicine, 311, 426-432.
40. Sugrue, D., McEvoy, M., Feely, J. & Drury, M.I. (1980) Hyperthyroidism in the land of Graves: results of treatment by surgery, radioiodine, and carbimazole in 837 Cases. Quarterly Journal of Medicine, 193, 61.
41. Tajiri, J., Noguchi, S., Murakami, T. & Murakami, N. (1990) Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Archives of Internal Medicine, 150, 621-624.
42. Tallstedt, L., Lundell, G., Torring, O., Wallin, G., Ljunggren, J., Blomgren, H. & Taube, A. (1991) Occurrence of ophthalmopathy after the treatment of Graves' hyperthyroidism. New England Journal of Medicine, 326, 1733-1738.
43. Tamai, H., Hayaki, I., Kawai, K., Komaki, G., Matsubayashi, H., Kuma, K., Kumagai, L.F. & Nagataki, K. (1995) Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. Journal of Clinical Endocrinology and Metabolism, 80, 1481-1484.
44. Tamai, H., Nakagawa, T., Fukino, O., Ohsako, N., Shinzato, R., Suematsu, H., Kuma, K., Matsuzuka, F. & Nagataki, S. (1980) Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy. Annals of Internal Medicine, 92, 488-490.
45. Tamai, H., Takaichi, Y., Morita, T., Komaki, G., Matsubayashi, H., Kuma, K., Walter, R., Kumagai, L.F. & Nagataki, S. (1989) Methimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clinical Endocrinology, 30, 525-530.
46. Törring, O., Tallstedt, L., Wallin, G., Lundell, G., Ljungren, J., Taube, J., Sääf, M., Hamberger, B. & The Thyroid Group. (1996) Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. Journal of Clinical Endocrinology and Metabolism, 81, 2986-2993.
47. Vitti, P., Rago, T., Chiovato, L., Pallini, S., Santini, F., Fiore, E., Rocchi, R., Martino, E. & Pinchera, A. (1997) Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid, 7, 369-375.
48. Weetman, A.P., McGregor, A.M. & Hall, R. (1984) Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clinical Endocrinology, 21, 163-172.
49. Weetman, A.P., Pickerill, A.P., Watson, P., Chaterjee, V.K. & Edwards, O.M. (1994) Treatment of Graves' disease with the block-replace regime of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse. Quarterly Journal of Medicine, 87, 337-341.
50. Weetman, A.P., Ratanachaiyavong, S., Middleton, G.W., Love, W., John, R., Owen, G.M., Darke, C., Lazarus, J.H., Hall, R. & McGregor, A.M. (1986) Prediction of outcome in Graves' disease after carbimazole treatment. Quarterly Journal of Medicine, 59, 409-419.
51. Werner, M.C., Romaldini, J.H., Bromberg, N., Werner, R. & Farah, C.S. (1989) Adverse effects related to thionamide drugs and their dose regime. American Journal of Medical Sciences, 297, 216-219.
52. Winsa, B., Dahlberg, P.A., Jansson, R., Ågren, H. & Karlsson, F.A. (1990) factors influencing the outcome of thyrostatic drug therapy in Graves' disease. Acta Endocrinolgica, 122, 722-728.
53. Wood, L.C. & Ingbar, S.H. (1979) Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. Journal of Clinical Investigations, 64, 1429-1436.